ArticlePediatric research2026
Clinical outcomes of influenza in individuals aged ≤20 years before and after COVID-19: a national analysis of mortality and complications.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Respiratory Infection-Related Pathogens in the Pediatric Intensive Care Unit During 2019-2024 in Hubei, China.Pathogens (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 pandemic has altered the typical annual pattern of influenza. We aim to assess its impact on influenza outcomes, especially on mortality, cardiovascular, and non-cardiovascular complications.
methodsThis study utilized discharge records from the National Inpatient Sample (NIS) for 2019 and 2022. We analyzed the data of hospitalized influenza patients (20 years and younger) using descriptive statistics and logistic regression models.
results29,270 influenza hospitalizations were identified in the pre-pandemic year and 29,860 in the post-mitigation year. The median age was 6 years (IQR: 2-12) in the post-mitigation year vs. 4 years (IQR: 1-9) in the pre-pandemic year, P < 0.001. Mortality and major cardiovascular complications, including myocarditis and tachyarrhythmias, showed no differences. Respiratory failure was more common in post-mitigation (21.4% vs. 12.7%), with nearly twice the risk in adjusted models [aOR = 1.92 (1.68-2.19), P < 0.001]. Invasive mechanical ventilation use decreased in the post-mitigation year by 30% [aOR = 0.7 (0.55-0.89), P = 0.004].
conclusionMortality and cardiovascular complications remained stable in pre- and post-mitigation year; however, post-pandemic influenza showed an increased risk of respiratory failure with a decreased invasive mechanical ventilation use. This suggests a shift in disease presentation and clinical management strategies in the post-mitigation period. IMPACT: Influenza's clinical profile in children has changed post-COVID, with increased respiratory failure and a shift to older affected age groups, while mortality and severe cardiovascular complications remain stable. This study is the first to systematically compare pediatric influenza outcomes, including all major complications and mortality, pre- and post-COVID-19, revealing specific shifts in disease presentation and demographics. Informs clinical vigilance, diagnostic strategies, and public health planning for pediatric influenza by highlighting shifts in hospitalization patterns and complications observed during the post-mitigation period. Findings support preparedness efforts recognizing temporal disruptions surrounding the pandemic.
Identifiers
41535402What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.